Search results
The American Macular Degeneration Foundation Showc | Newswise
Newswise· 7 days ago“Our goal is to advance the development of treatments, tools and usable information that improve the lives of those affected by AMD and, just as important, a sense of hope ...
Age-Related Macular Degeneration: Putting a Hole in Our World
WebMD· 6 days agoWhen we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...
Earnings call: Lineage Cell Therapeutics reports positive OpRegen trial results By Investing.com
Investing.com· 5 days agoIn a recent earnings call, Lineage Cell Therapeutics (NYSE:LCTX), a biotechnology company...
Ranibizumab is safe for treating retinopathy of prematurity
UB Reporter· 21 hours agoFor several decades, laser therapy has been the primary treatment method for ROP. Laser treatment involves burning the infant’s peripheral retina to stop ...
Red flag sign in your eye of silent killer that causes 75,000 UK deaths a year
Daily Express· 5 days agoHigh blood pressure - or hypertension - is a medical condition that is thought to affect around a...
Disease latency bias and the protective effect of metformin against age-related macular degeneration...
Nature· 5 days agoThere arises a spurious association between the older medication and absence of the condition causing symptoms. Metformin is an old medication, but it remains the first-line treatment ...
Ocugen completes second cohort dosing in Stargardt trial By Investing.com
Investing.com· 12 hours agoThe trial represents a potential breakthrough for patients with this inherited retinal disease,...
Q1 2024 Ocugen Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 23 hours agoTo better understand the experience of one of our Phase 1/2 clinical trial patients, I encourage you to watch this video and the patient's section of our website. Moving on to our development ...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look
Guru Focus· 5 days agoOn May 9, 2024, Adverum Biotechnologies Inc (ADVM, Financial), a trailblazer in gene therapy for ocular diseases, disclosed its financial outcomes for the first quarter of 2024 through its 8 ...
Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8%
ETF DAILY NEWS· 7 days agoSkye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report)’s stock price was down 1.8% during trading on Wednesday . The company traded as low as $12.32 and last traded at $12.50. Approximately 29,170 ...
